Bezlotoxumab for Clostridium difficile Infection Complicating Inflammatory Bowel Disease

Kelly, CP, Wilcox, MH orcid.org/0000-0002-4565-2868, Glerup, H et al. (4 more authors) (2018) Bezlotoxumab for Clostridium difficile Infection Complicating Inflammatory Bowel Disease. Gastroenterology, 155 (4). pp. 1270-1271. ISSN 0016-5085

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2018 by the AGA Institute. This is an author produced version of a paper published in Gastroenterology. Uploaded in accordance with the publisher's self-archiving policy.
Dates:
  • Published: October 2018
  • Accepted: 18 June 2018
  • Published (online): 15 September 2018
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > Institute of Molecular Medicine (LIMM) (Leeds) > Section of Molecular Gastroenterology (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 08 Mar 2019 12:25
Last Modified: 14 Sep 2019 00:39
Status: Published
Publisher: Elsevier
Identification Number: https://doi.org/10.1053/j.gastro.2018.06.080

Share / Export

Statistics